Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail DAIDSRSCwebsitesupport@tech-res.com for assistance.

Drugs

Drug Name Drug Company Sort descending PI Date Risk List Available?
Lopinavir/Ritonavir (Kaletra) AbbVie December 2019 YES
Ritonavir (Norvir) Tablets/Oral Solution AbbVie December 2019
Hydroxychloroquine - New Actavis Pharma November 2017
Ribavirin Aurobindo Pharma Limited October 2018
Efavirenz Aurobindo Pharma Limited May 2011
Nevirapine (Viramune) Boehringer Ingelhiem Pharmaceuticals September 2018 YES
Efavirenz (Sustiva) Bristol-Myers Squibb October 2017 YES
Intralipid Fresenius Kabi Limited April 2016
Ledipasvir/Sofosbuvir (Harvoni) Gilead November 2019
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) Gilead Sciences August 2019
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (Atripla) Gilead Sciences October 2019 YES
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (Genvoya) Gilead Sciences February 2019
Emtricitabine/Tenofovir Alafenamide (Descovy) - New Gilead Sciences January 2020
Tenofovir Disoproxil Fumarate (Viread) Gilead Sciences April 2019 YES
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences May 2018 YES
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) Gilead Sciences April 2017
Zidovudine (Retrovir) Capsules, Syrup and IV Injection GlaxoSmithKline September 2018 YES
Abacavir/Lamivudine (Epzicom) GlaxoSmithKline May 2019
Lamivudine/Zidovudine (Combivir) GlaxoSmithKline April 2018 YES
Lamivudine (Epivir) GlaxoSmithKline May 2019 YES